Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
about
Efficacy of pharmacotherapies for short-term smoking abstinance: a systematic review and meta-analysis.Effectiveness of smoking cessation therapies: a systematic review and meta-analysisGastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysisAlcoholism: A Systems Approach From Molecular Physiology to Addictive BehaviorSmoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 centuryNicotine receptor partial agonists for smoking cessationInterventions for smokeless tobacco use cessationNicotine receptor partial agonists for smoking cessationAntidepressants for smoking cessationPharmacological interventions for smoking cessation: an overview and network meta-analysisInterventions for preventing weight gain after smoking cessationNicotine receptor partial agonists for smoking cessationInterventions for preventing weight gain after smoking cessationAntidepressants for smoking cessationRisk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysisSmoking cessation therapy during pregnancyPhantasmidine: an epibatidine congener from the ecuadorian poison frog Epipedobates anthonyiRisk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysisEffect of varying levels of disease management on smoking cessation: a randomized trialGabapentin for smoking cessationPositive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in ratsSmoking and suicide: a brief overviewMetabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotineDepression and smoking cessation: does the evidence support psychiatric practice?Helping patients to reduce tobacco consumption in oncology: a narrative reviewAre Smoking Cessation Treatments Associated with Suicidality Risk? An OverviewVarenicline for smoking cessation: a narrative review of efficacy, adverse effects, use in at-risk populations, and adherenceHIV and smoking: associated risks and prevention strategiesSmoking Use and Cessation Among People with Serious Mental IllnessCombination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trialsCardiovascular effects of pharmacologic therapies for smoking cessationTargeting the noradrenergic system for gender-sensitive medication development for tobacco dependenceRational development of addiction pharmacotherapies: successes, failures, and prospectsA key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administrationEnantiopure Cyclopropane-Bearing Pyridyldiazabicyclo[3.3.0]octanes as Selective α4β2-nAChR Ligands.Mechanistic insights into nicotine withdrawal.Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysisBiologic Approaches to Treat Substance-Use DisordersNew mechanisms and perspectives in nicotine withdrawalEmerging drugs for the treatment of tobacco dependence: 2014 update
P2860
Q21093272-62C0027D-B11F-4818-8E0F-B5173C507A30Q21093304-8A413EFA-A4BF-459F-A9CF-5501550C65DFQ21254640-8A4F7C02-78D4-4897-A96A-FDE340C9406DQ22241964-0150F94D-3F35-4DE4-BB9D-CD8D9A160D82Q22305613-43484733-80C3-402A-926C-EB1C09BA0564Q24185773-85C9A147-C7F1-4D67-996E-A44080BB5A1BQ24186373-0AFC5D03-4CB7-408C-A5CC-01CCBF954705Q24200322-49C86D2D-AB8D-454D-9C44-A117ED0453B0Q24201167-938FD8D2-66B2-4D24-ADDB-6B82AF97F5EEQ24202961-7094C2D7-A17D-4885-8049-1FBC545728F9Q24203883-16829B17-874C-49F4-AE6D-1306401F7851Q24235456-78C37E92-6CBF-4E2B-8852-6125060BD0B3Q24241751-0662A5AB-DD05-4F01-9C7B-3DBEE34B26CCQ24246426-E32CA6F5-C860-4A13-8EF1-7CBF54B4960FQ24602146-9D6FDFB1-E32B-4A66-9CA2-F7F16A503E31Q24620757-0DE495B3-BF27-4C06-9645-063CCC92A1FCQ24625408-12EBCFE7-566D-4F8E-BC39-5C4EE8896162Q24628826-58CF07FE-6A51-44F8-8E3A-3B0AE7D53ADAQ24645158-2F00244F-58B0-4311-B9E8-F9B704571F68Q24645235-677C937A-E54E-4968-AFE9-BC343A7645A3Q24647023-AB032A30-14D0-4CB8-B350-133C003E7842Q24655785-30DAA124-B9E1-4886-8A28-9AA3E30B93A1Q24655916-EBE7A29A-AC6C-42FD-BB38-044AD04A196DQ24658121-09CC72A9-6F0D-4DDA-A50C-5C4C07DF44D9Q26738416-50949E67-D1D2-4608-954E-C7F6C4A76CE7Q26747804-483B25CA-6D60-4832-8E8D-B2A2326CD15BQ26751374-42242EEE-F938-49B0-965E-B953A3C9AD86Q26772025-450C13EA-95E1-4565-A0F6-A6302EA3BE84Q26785461-06157791-8B32-4924-9915-8B45F36390B6Q26801320-C6F6FDF6-7175-46BE-9CC8-43C62EBB8D22Q26849379-6B28FD61-E696-4BD4-8A42-D7024B8B8B57Q26999258-F35D9C70-9E3D-4E96-B850-C723F36883BBQ27025533-E2005D18-96EC-4BEE-9949-D115D740EC4AQ27312608-4B085EF8-8638-4675-9609-6B408DCD1CB9Q27335322-51FB5EEC-DCD1-4A24-B8A6-E7DFC51A552CQ27687645-DCCAC128-69F0-416C-96F8-ABF6BF83F63AQ28083649-A6B1F706-441C-4982-83CB-04462B34A754Q28085073-DFF29296-660E-489B-AB44-67AA8C1EF71BQ28111991-985CF40F-0CCB-4C7F-9F46-0F45EA117E8BQ28236453-72908CC4-4566-4819-910F-1CE987D4C91D
P2860
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Efficacy of varenicline, an al ...... a randomized controlled trial.
@ast
Efficacy of varenicline, an al ...... a randomized controlled trial.
@en
type
label
Efficacy of varenicline, an al ...... a randomized controlled trial.
@ast
Efficacy of varenicline, an al ...... a randomized controlled trial.
@en
prefLabel
Efficacy of varenicline, an al ...... a randomized controlled trial.
@ast
Efficacy of varenicline, an al ...... a randomized controlled trial.
@en
P2093
P356
P1476
Efficacy of varenicline, an al ...... a randomized controlled trial.
@en
P2093
Clare B Billing
Douglas E Jorenby
Eric J Watsky
J Taylor Hays
Jason Gong
Karen R Reeves
Kathryn E Williams
Nancy A Rigotti
Salomon Azoulay
Varenicline Phase 3 Study Group
P356
10.1001/JAMA.296.1.56
P407
P577
2006-07-01T00:00:00Z